Cytokine Production by Hepatic Anaplastic Large-Cell Lymphoma Presenting as a Rheumatic Syndrome

Seminars in Arthritis and Rheumatism

Volumn 37, Issue 1, 2007, Pages 63-67

  Siebert, Stefan ^a   Amos, Nicholas ^b   Williams, Bryan D ^b   Lawson, Thomas M ^c  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c PRINCESS OF WALES HOSPITAL   (United Kingdom)

Author keywords

cytokines; fever; inflammation; lymphoma

Indexed keywords

CISPLATIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 6; INTERLEUKIN 8; LOMUSTINE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE RELEASE; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LARGE CELL LYMPHOMA; LIVER DISEASE; LIVER RESECTION; MALE; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHEUMATIC DISEASE; TUMOR RECURRENCE;

ADULT; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; RHEUMATIC DISEASES;

EID: 34447626310     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2006.12.007     Document Type: Article

References (21)

1. Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74 (1989) 1360-1367
2. Jourdan M., Bataille R., Seguin J., Zhang X.G., Chaptal P.A., and Klein B. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum 33 (1990) 398-402
3. Ishizawa M., Okabe H., Matsumoto K., Hukuda S., Hodohara K., and Ota S. Anaplastic large cell Ki-1 lymphoma with bone involvement: report of two cases. Virchows Arch 427 (1995) 105-110
4. Nagasaka T., Nakamura S., Medeiros L.J., Juco J., and Lai R. Anaplastic large cell lymphomas presented as bone lesions: a clinicopathologic study of six cases and review of the literature. Mod Pathol 13 (2000) 1143-1149
5. Bakshi N.A., Ross C.W., Finn W.G., Valdez R., Ruiz R., Koujok K., et al. ALK-positive anaplastic large cell lymphoma with primary bone involvement in children. Am J Clin Pathol 125 (2006) 57-63
6. Kubonishi I., Bandobashi K., Murata N., Daibata M., Ido E., Sonobe H., et al. High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol 98 (1997) 450-452
7. Shimamoto T., Hayashi S., Ando K., Yguchi M., Miyazawa K., Kimura Y., et al. Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy. Am J Hematol 66 (2001) 49-52
8. Sgrignoli A., and Abati A. Cytologic diagnosis of anaplastic large cell lymphoma. Acta Cytol 41 (1997) 1048-1052
9. Stein H., Mason D.Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 (1985) 848-858
10. Stein H., Foss H.D., Durkop H., Marafioti T., Delsol G., Pulford K., et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96 (2000) 3681-3695
11. Rimokh R., Magaud J.P., Berger F., Samarut J., Coiffier B., Germain D., et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 71 (1989) 31-36
12. Kaneko Y., Frizzera G., Edamura S., Maseki N., Sakurai M., Komada Y., et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73 (1989) 806-813
13. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K., Shapiro D.N., Look A.T., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 267 (1995) 316-317
14. ten Berge R.L., Dukers D.F., Oudejans J.J., Pulford K., Ossenkoppele G.J., de Jong D., et al. Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma. Blood 93 (1999) 2688-2696
15. Hsu S.M., Waldron J., Xie S.S., and Hsu P.L. Hodgkin's disease and anaplastic large cell lymphoma revisited. 1. Unique cytokine and cytokine receptor profile distinguished from that of non-Hodgkin's lymphomas. J Biomed Sci 2 (1995) 302-313
16. Barton B.E. IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation. Immunol Res 23 (2001) 41-58
17. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 92 (2001) 1684-1688
18. Ganapathi M.K., May L.T., Schultz D., Brabenec A., Weinstein J., Sehgal P.B., et al. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun 157 (1988) 271-277
19. Kurzrock R. Cytokine deregulation in hematological malignancies: clinical and biological implications. Clin Cancer Res 3 (1997) 2581-2584
20. Beck J.T., Hsu S.M., Wijdenes J., Bataille R., Klein B., Vesole D., et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 330 (1994) 602-605
21. Nishimoto N., Sasai M., Shima Y., Nakagawa M., Matsumoto T., Shirai T., et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95 (2000) 56-61